| Sep 18 2020 |
With Retail Bankruptcies on the Rise, Opportunities for Distressed M&A Increase |
Hunton Andrews Kurth |
| Sep 17 2020 |
Treasury Issues Final Rule Amending CFIUS Mandatory Filing Requirements |
Mintz |
| Sep 17 2020 |
Department of Justice Issues Updated Merger Remedies Manual |
Epstein Becker & Green, P.C. |
| Sep 16 2020 |
DOJ Issues New Merger Remedies Manual, Emphasizes Structural Remedy Preference |
Bracewell LLP |
| Sep 15 2020 |
French and American Luxury Brands Litigate Delayed Merger |
MoginRubin |
| Sep 12 2020 |
United Kingdom Competition Currents: September 2020 |
Greenberg Traurig, LLP |
| Sep 11 2020 |
New DOJ Merger Remedies Manual Cites Strong Preference for Structural Remedies - New Openness to Private Equity Buyers |
Proskauer Rose LLP |
| Sep 11 2020 |
363 Sales as a Health Care M&A Tool, Part 2 – Pros and Cons for Buyers and Sellers |
Mintz |
| Sep 8 2020 |
Private Equity Purchasers and SPACs May Be "Preferred" Divestiture Buyers under New DOJ Guidelines for Merger Remedies |
Cadwalader, Wickersham & Taft LLP |
| Sep 8 2020 |
Justice Department Revises Merger Remedies Guidelines |
Cadwalader, Wickersham & Taft LLP |
| Sep 8 2020 |
DOJ Antitrust Division Releases New Guidance on Merger Remedies for First Time Since Withdrawal of 2011 Policy Guide to Merger Remedies |
Mintz |
| Sep 8 2020 |
DOJ Antitrust Division Issues New Manual on Merger Guidelines |
Faegre Drinker |
| Sep 2 2020 |
Energy & Sustainability M&A Activity – September 2020 |
Mintz |
| Sep 2 2020 |
Antitrust M&A Snapshot | Q2 2020 |
McDermott Will & Emery |
| Aug 31 2020 |
Can a Trustee Prosecute Fraudulent Transfer and Tortious Interference Claims if No Event of Default Has Occurred? |
Faegre Drinker |
| Aug 28 2020 |
Five Things to Consider When Selling Your CBD Business |
Ward and Smith, P.A. |
| Aug 27 2020 |
COVID-19: Employment Issues in Health Care Mergers & Acquisitions in the Era of COVID-19 |
K&L Gates LLP |
| Aug 27 2020 |
Announced Changes at the Antitrust Division May Presage Greater Enforcement in Health Care |
Epstein Becker & Green, P.C. |
| Aug 24 2020 |
Delaware Court of Chancery Further Clarifies the “Ab Initio” Requirement in Finding That Discussions Between the Controlling Stockholder and a Minority Stockholder Precluded the Application of MFW |
Cadwalader, Wickersham & Taft LLP |
| Aug 24 2020 |
Public Hospital M&A: Know Your Stakeholders |
McDermott Will & Emery |
| Aug 19 2020 |
Driving the Deal: Public Hospital M&A and Stakeholder Buy-In [Podcast] |
McDermott Will & Emery |
| Aug 19 2020 |
DOJ Issues Long-Awaited FCPA Advisory Opinion |
McDermott Will & Emery |
| Aug 13 2020 |
Be Mindful of Overlapping Officers and Directors |
Epstein Becker & Green, P.C. |
| Aug 11 2020 |
Elimination of Digital DIY Tax Prep Disrupter Should Concern Antitrust Law Enforcers |
MoginRubin |
| Aug 10 2020 |
5 Questions with Matthew Weinberg: Merger Retrospectives |
Cornerstone Research |
| Aug 7 2020 |
Justice Department Files Suit to Enjoin Acquisition of Minority Share of Community Hospital; Shows Pitfalls of A Merger “Plan B” and Provides Roadmap of What Not to Say During Deal Negotiations |
Mintz |
| Aug 6 2020 |
FTC Approves Elanco’s $7.6B Acquisition of Bayer Animal Healthcare, Sets Divestiture Conditions |
MoginRubin |
| Aug 4 2020 |
Chancery Court Holds Late Breach of Fiduciary Duty Claim is Barred by Laches |
K&L Gates LLP |
| Jul 30 2020 |
Trends in Merger Investigations and Enforcement at the European Commission 2019 |
Cornerstone Research |
| Jul 28 2020 |
Chancery Court Declines to Dismiss Breach of Contract, Implied Covenant and Declaratory Judgment Claims Stemming from Termination Purportedly for Cause |
K&L Gates LLP |
| Jul 28 2020 |
What Impact has Coronavirus had on Doing Healthcare Deals? [WEBINAR] |
McDermott Will & Emery |
| Jul 27 2020 |
The Impact of COVID-19 on M&A Transactions — Part II: Deal Terms |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 27 2020 |
Sixth Circuit Says No Shortcuts to Standing in Tennessee Antitrust Case |
Squire Patton Boggs (US) LLP |
| Jul 27 2020 |
The Impact of COVID-19 on M&A Transactions — Part I: Due Diligence And Operational Issues |
Sheppard, Mullin, Richter & Hampton LLP |
| Jul 23 2020 |
W&I Insurance: Changes, Impact and Opportunities for Investors Resulting from COVID-19 (Part 2) [PODCAST] |
Proskauer Rose LLP |
